Neuroscience
Optogenetics
100%
Electrophysiology
89%
Excitability
66%
Ictal
59%
Visual Cortex
59%
Status Epilepticus
59%
Chromaffin Cell
59%
Exocytosis
59%
Potassium Channel
59%
Astrocyte
59%
Focal Epilepsy
49%
Neuronal Activity
47%
Hippocampus
39%
Action Potential
33%
Neurological Disorder
33%
Dynamic Causal Modeling
29%
Megalencephalic Leukoencephalopathy with Subcortical Cysts
29%
Ultrasonography
29%
Optical Imaging
29%
Evoked Seizure
29%
Lentivirus Vector
29%
Leukodystrophy
29%
Calcium Channel
29%
Purinergic P2X1 Receptor
29%
Face
29%
Kv1.1
29%
Synaptic Physiology
29%
Extracellular Matrix
29%
Alzheimer's Disease
29%
Epileptogenesis
29%
Receptor Potential
29%
Purinergic P2X7 Receptor
29%
Firing Rate
29%
Local Field Potential
29%
Functional Magnetic Resonance Imaging
29%
Spreading Cortical Depression
29%
Purinergic P2X4 Receptor
29%
Mast Cell
29%
Calmodulin
29%
Functional Connectivity
29%
Tonic-Clonic Seizure
29%
Neurotechnology
29%
Patch Clamp
28%
Adenosine Triphosphate
25%
Potassium Channel Kv1.1
24%
Temporal Lobe Epilepsy
24%
Opsin
23%
Anticonvulsant
22%
Virus Vector
19%
Pentylenetetrazol
19%
Medicine and Dentistry
Gene Therapy
65%
Graphene
59%
Epileptic Seizure
47%
Apoplexy
44%
Translational Research
32%
Neurologic Disease
32%
Patient with Epilepsy
29%
Functional Magnetic Resonance Imaging
29%
Purinergic P2X1 Receptor
29%
Potassium Channel
29%
Brain Injury
29%
Cortical Spreading Depression
29%
Evoked Seizure
29%
Mast Cell
29%
Purinergic P2X4 Receptor
29%
Purinergic P2X7 Receptor
29%
Injury
29%
Adenosine Triphosphate
29%
Sudden Unexpected Death in Epilepsy
29%
Pathophysiology
22%
Lentivirus Vector
17%
TRPM7
16%
Brain Disease
14%
Clinical Management
14%
Biological Marker
14%
Migraine with Aura
14%
High Frequency Oscillations
14%
Optogenetics
11%
Temporal Lobe Epilepsy
11%
Two-Photon Microscopy
11%
Partial Seizure
11%
Brain Ischemia
9%
Reverse Transcription Polymerase Chain Reaction
9%
Patch Clamp
9%
Purinergic P2X Receptor
9%
Anesthetic Agent
9%
Diseases
8%
Transient Receptor Potential Channel M7
8%
Combination Therapy
7%
Drug Therapy
7%
Epilepsy Surgery
5%
Brain Function
5%
Ictal
5%
Gene Expression Regulation
5%
Functional Connectivity
5%
Adeno Associated Virus Vector
5%
Hippocampus
5%
Excitability
5%
Promoter Region
5%
Brain Tissue
5%
Pharmacology, Toxicology and Pharmaceutical Science
Epileptic State
49%
Combination Therapy
29%
Tetanus Toxin
29%
Potassium Channel
29%
Neuronal Channelopathy
29%
Purinergic P2X1 Receptor
29%
Purinergic P2X7 Receptor
29%
Purinergic P2X4 Receptor
29%
Adenosine Triphosphate
29%
Lentivirus Vector
29%
Mouse
29%
Transgenic Mouse
29%
Alzheimer's Disease
29%
Zebra Fish
29%
Temporal Lobe Epilepsy
19%
Rat Model
19%
Focal Epilepsy
19%
Amyloid A Protein
14%
Tetrylammonium
14%
4-Aminopyridine
14%
Isotopes of Potassium
14%
Mouse Model
14%
Disease
14%
Transient Receptor Potential Channel M7
14%
Pentylenetetrazole-Induced Seizure
9%
Epileptic Absence
9%
Syndrome
9%
Purinergic P2X Receptor
9%
Potassium Channel Kv1.1
9%
Mutagenesis
9%
Complex Partial Seizure
9%
Preclinical Study
9%
Placebo
9%
Seizure
9%
Epileptic Discharge
9%
RNA Directed DNA Polymerase
9%
Adeno Associated Virus Vector
9%